Journal of Inflammation Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-04-30 ms2000000125538392 来自四川省

前往app查看评论内容

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-04-14 120f50f1m32(暂无昵称) 来自安徽省

偏重的研究方向：免疫;炎症
经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，

6 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-03-12 ms2000002102678296 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：看了论坛好久，今天回馈给兄弟们一个时间线
12 December 2024 Peer review selection
13 December 2024 Peer review invitations sent
13 December 2024 First peer reviewer allocated
2 January 2025 First report returned
22 January 2025 Second or more peer reviewer reports returned
22 January 2025 Report sent to the Editor-in-Chief
24 January 2025 Report: revise with changes
31 January 2025 Resubmission pending
6 February 2025 Resubmitted manuscript received
13 February 2025 Query regarding revised manuscript
15 February 2025 Processing revised manuscript
21 February 2025 Sent to Editor-in-Chief for acceptance or rejection
21 February 2025 Peer reviewer(s) second round
3 March 2025 Peer reviewer(s) second round completed
March 2025 Accepted for publication, invoice sent

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2024-11-29 一个胖子YH 来自山东省

偏重的研究方向：心脏;炎症
经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊

20 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-04-11 ms8000002098570468 来自江苏省

先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。

8 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-04-13 120f50f1m32(暂无昵称) 来自安徽省

偏重的研究方向：免疫;炎症
经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-01-15 ms1000000205841052 来自山东省

4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭

25 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2022-06-13 ms5000001171014765

4B已经14天了，怎么会这么慢啊....

55 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2025-02-18 ms1000000205841052 来自山东省

偏重的研究方向：生信干湿结合
经验分享：有老哥拒稿后argue过吗

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262885, encodeId=81042262885e3, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f88345066, createdName=ms2000000125538392, createdTime=Wed Apr 30 11:31:36 CST 2025, time=2025-04-30, status=0, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2260439, encodeId=9de322604399c, content=偏重的研究方向：免疫;炎症 经验分享：2.1号投稿，4.14接收，只有一轮审稿，修回后没有第二轮审稿直接接收，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Mon Apr 14 20:04:29 CST 2025, time=2025-04-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2255761, encodeId=adac2255e6167, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：看了论坛好久，今天回馈给兄弟们一个时间线 12 December 2024 Peer review selection 13 December 2024 Peer review invitations sent 13 December 2024 First peer reviewer allocated 2 January 2025 First report returned 22 January 2025 Second or more peer reviewer reports returned 22 January 2025 Report sent to the Editor-in-Chief 24 January 2025 Report: revise with changes 31 January 2025 Resubmission pending 6 February 2025 Resubmitted manuscript received 13 February 2025 Query regarding revised manuscript 15 February 2025 Processing revised manuscript 21 February 2025 Sent to Editor-in-Chief for acceptance or rejection 21 February 2025 Peer reviewer(s) second round 3 March 2025 Peer reviewer(s) second round completed March 2025 Accepted for publication, invoice sent , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9fa5603307, createdName=ms2000002102678296, createdTime=Wed Mar 12 16:28:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260075, encodeId=310122600e51e, content=先在2gx 1周，然后2g状态12天了，需要催一下吗？前面每个阶段基本上都是一个星期一个进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dad9268537, createdName=ms8000002098570468, createdTime=Fri Apr 11 18:48:54 CST 2025, time=2025-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2260212, encodeId=39b9226021217, content=偏重的研究方向：免疫;炎症 经验分享：到i n v o i c i n g那一步了是不是就代表基本接收了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19302219324, createdName=120f50f1m32(暂无昵称), createdTime=Sun Apr 13 11:33:10 CST 2025, time=2025-04-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248109, encodeId=190722481099d, content=4B - RESUBMITTED MANUSCRIPT RECEIVED持续半个月了，需要发邮件催一下吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Jan 15 08:53:30 CST 2025, time=2025-01-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1226104, encodeId=99241226104d3, content=4B已经14天了，怎么会这么慢啊.... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf45412573, createdName=ms5000001171014765, createdTime=Mon Jun 13 08:18:25 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252505, encodeId=b3892252505da, content=偏重的研究方向：生信干湿结合 经验分享：有老哥拒稿后argue过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Tue Feb 18 16:06:41 CST 2025, time=2025-02-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2236695, encodeId=72f02236695d5, content=偏重的研究方向：生信干湿结合 经验分享：1e大约需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7378502749, createdName=ms1000000205841052, createdTime=Wed Nov 13 13:48:05 CST 2024, time=2024-11-13, status=1, ipAttribution=山东省)]

2024-11-13 ms1000000205841052 来自山东省

偏重的研究方向：生信干湿结合
经验分享：1e大约需要多久啊

21 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务